May 01, 2025

FDA Approves Intranasal DHE for Acute Migraine Relief

The FDA has approved Atzumi for the acute treatment of migraine with or without aura in adults.

Conexiant

May 01, 2025

Health Care Shortage: Who’s Left Out?

“The ER then says, ‘OK, you should follow up with your primary care provider,’ and they’re like, ‘We don’t have one.’”

KFF Health News

May 01, 2025

Psilocybin Shows Promise for Parkinson's Disease

First clinical trial demonstrates psilocybin therapy significantly improves depression, anxiety, and motor symptoms.

Conexiant

May 01, 2025

Race, Sex Gaps Reshape Hearing Loss Landscape

A new study reveals significant disparities in hearing loss prevalence: 60.7% of White males are affected, compared with 29.2% of Black females.

Conexiant

April 30, 2025

FDA Approves FcRn Blocker for Broad gMG Use

The first FcRn blocker for both adult and pediatric generalized myasthenia gravis has been approved by the FDA, based on data showing sustained symptom improvement and IgG reduction in clinical trials.

Conexiant

April 29, 2025

Foley Catheter Management: New Best Practices, Pitfalls

Foley catheter use is associated with a wide range of complications, from infections to urethral erosion.

Conexiant

April 29, 2025

Surgical Management of Foreign Body Ingestion in Adults: Case Series

Diagnosis relies heavily on a careful history, including the nature of the ingested material, and complementary imaging studies.

Conexiant

April 29, 2025

Pediatric Concussion Recovery Takes Months

"Most children reach optimal functioning within 3 to 6 months; this information should be included in anticipatory guidance and reassurance to families."

Conexiant

April 29, 2025

RadSearch Transforms Radiology Report Retrieval 

RadSearch could enhance radiologists' ability to find precedent cases.

Conexiant